EXE vs WELL, which one are you guys feeling better about right now?

{"summary": "Author compares Extendicare (EXE) and WELL Health (WELL), leaning toward WELL for recovery upside while viewing EXE as the safer, better-run but already-run-up business.", "reason": "The author expresses a directional preference for WELL based on valuation and recovery potential, and provides a fundamental assessment of EXE's current valuation relative to its recent performance.", "ideas": [{"symbol": "WELL.TO", "direction": "long", "thesis": "Author leans toward WELL Health because the stock has fallen sharply and expectations appear already low, implying potential recovery upside over the next 6 months. The bull case rests on continued revenue growth and management raising guidance, though the author flags heavy debt, aggressive acquisitions, and profits that look weaker than adjusted EBITDA as key risks.", "thesis_short": "Leaning WELL for beaten-down recovery upside", "quote": "I’m leaning WELL just because it feels like it has more room to recover", "confidence": 0.7, "sentiment": 0.5, "timeframe": "next 6 months"}, {"symbol": "EXE.TO", "direction": "watch", "thesis": "Author views Extendicare as the more profitable, stable, dividend-paying business with a better balance sheet and strong revenue growth, especially after the CBI acquisition. The main concern is that the stock has already had a massive run, raising doubt about how much upside remains, so the author treats it as the safer hold rather than the higher-upside pick.", "thesis_short": "EXE safer but upside may be spent", "quote": "EXE = better company but maybe most of the upside already happened?", "confidence": 0.7, "sentiment": 0.2, "timeframe": "next 6 months"}], "model": "gemini-3.1-flash-lite", "failure_count": 0, "verified": true, "extraction_model": "deepseek-flash"}